Dr. Shayla Bergmann
Claim this profileMedical University of South Carolina
Studies Sickle Cell Disease
Studies Von Willebrand Disease
9 reported clinical trials
11 drugs studied
Area of expertise
1Sickle Cell Disease
HbSS positive
HbSC positive
HbSβ0-thalassemia positive
2Von Willebrand Disease
Affiliated Hospitals
Clinical Trials Shayla Bergmann is currently running
Recombinant Von Willebrand Factor
for Von Willebrand Disease
The main aim of the study is to evaluate the effectiveness of prophylaxis with vonicog alfa (recombinant von Willebrand factor \[rVWF\]) in children. This study will enroll those participants who have been previously treated with VWF product or with a plasma-derived VWF (pdVWF) product. In this study, participants will be treated with vonicog alfa (rVWF) for 12 months. During the study, participants will visit the study clinic 5 times after treatment initiation.
Recruiting2 awards Phase 34 criteria
rVWF +/− ADVATE
for Von Willebrand Disease
The main aim of the study is to check effectiveness, side effects, and tolerability of vonicog alfa (recombinant von Willebrand factor \[rVWF\]), with or without ADVATE, in the treatment and control of nonsurgical bleeding events in pediatric participants (less than (\<)18 years of age) with severe hereditary von Willebrand disease (VWD). The participants will be treated with vonicog alfa for 12-18 months. Their von Willebrand Disease will be treated by their doctor according to their doctor's usual clinical practice. During the study, participants will be followed up at clinics or over telephone calls.
Recruiting2 awards Phase 3
More about Shayla Bergmann
Clinical Trial Related6 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Shayla Bergmann has experience with
- Crizanlizumab
- Voxelotor
- Placebo
- SHP655
- Recombinant Von Willebrand Factor (rVWF)
- ADVATE
Breakdown of trials Shayla Bergmann has run
Sickle Cell Disease
Von Willebrand Disease
Priapism
Sickle Cell Anemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Shayla Bergmann specialize in?
Shayla Bergmann focuses on Sickle Cell Disease and Von Willebrand Disease. In particular, much of their work with Sickle Cell Disease has involved HbSS positive patients, or patients who are HbSC positive.
Is Shayla Bergmann currently recruiting for clinical trials?
Yes, Shayla Bergmann is currently recruiting for 2 clinical trials in Charleston South Carolina. If you're interested in participating, you should apply.
Are there any treatments that Shayla Bergmann has studied deeply?
Yes, Shayla Bergmann has studied treatments such as Crizanlizumab, Voxelotor, Placebo.
What is the best way to schedule an appointment with Shayla Bergmann?
Apply for one of the trials that Shayla Bergmann is conducting.
What is the office address of Shayla Bergmann?
The office of Shayla Bergmann is located at: Medical University of South Carolina, Charleston, South Carolina 29425 United States. This is the address for their practice at the Medical University of South Carolina.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.